Skip to content Skip to footer

International Cannabis Weekly: 269

October 14, 2022

Highlights

Share this story

FINAL AGENDA NOW RELEASED FOR BUSINESS OF CANNABIS: NEW YORK

The final agenda for Business of Cannabis: New York has been released and we’re excited to be bringing you a day-long programme to highlight the promise of New York as the new global capital of cannabis.

On 3 November, we cover the most pertinent trends within the industry and touch upon the areas of regulation, investment, innovation, social equity and much, much more. View the full agenda today.

VIEW THE AGENDA »

BOOK TICKETS »

NYC MAYOR APPOINTS DASHEEDA DAWSON AS CANNABIS NYC DIRECTOR

READ MORE »

A KEY STUDY INTO THE COST-BENEFIT OF CANNABIS ON THE NHS HAS LAUNCHED

READ MORE »

Highlights

Share this story
Europe
  • AVAAY Medical launches new medical cannabis strains for patients on the German market.
  • Legal challenges against Juicy Fields are growing, but concerns are being raised about ‘putting blame on victims’.
  • Ethypharm Germany is set to hold its second expert consultation on medicinal cannabis.
  • Akanda becomes the second cannabis company in less than six months to face possible NASDAQ delisting.
  • A new report has found that hemp has the potential to make Scotland’s agricultural sector carbon neutral.
  • Campaigners state that adverts for an illegal cannabis brand demonstrate the huge demand for the plant.
  • Senior partners of BCL Solicitors LLP share their views on a blueprint for the UK cannabis industry.
  • The Social Affairs Commission in France extends the extension of the experimentation of medical cannabis.

 

Highlights

Share this story
Stocks

Highlights

Share this story
United States

Highlights

Share this story
Sponsorship

FINAL CALL TO SPONSOR THE ASIAN CANNABIS REPORT

This is your final call for a unique opportunity to sponsor the Asian cannabis report and promote your business to one of the largest audiences in the global cannabis industry. Enquire by the end of this week to avoid missing out. 

Get in front of the readers of the report: retailers, investors and those from the pharma industry who are looking to diversify into the cannabis space. As the cannabis market across Asia continues to grow, sponsorship is an invaluable opportunity to position your brand at the forefront of the industry.

SPONSOR THE REPORT »

Highlights

Share this story
Canada

Highlights

Share this story
LATAM & The Caribbean
  • Prime Minister Drew has said that St Kitts could become the next Caribbean nation to establish a medical cannabis industry.
  • Cannabis Conicet, a technology-based public company, has been formed to promote the Argentine cannabis industry.
  • The 2nd edition of the THC Expo will bring together the Chilean cannabis community.
  • A new agency in Argentina, ARICCAME, will be in charge of regulation and control and the issuing of licences for cannabis.
  • ADREXpharma imports highly potent cannabis flowers from Colombia for the first time.
  • Brazil has elected 11 pro-cannabis deputies for the legislature, 5 federal and 6 state.
  • Brazilian cannabis associations reaffirm their fight for a more democratic access to medical cannabis.

Highlights

Share this story
Report

In 2021, the North American cannabis industry continued to grow and showed more promise than ever, with New York, New Jersey, Virginia, New Mexico, Montana and Connecticut all enacting, amending or passing adult-use cannabis legalisation.

There has also been a wealth of optimism for full federal legalisation in the US after President Biden was elected and the Democrats took control of the Senate. This has been further affirmed by the news last week that Biden is serious about cannabis reform, pardoning those with minor cannabis possession convictions. 

DOWNLOAD THE REPORT »

Highlights

Share this story
APAC
  • Japan’s Ministry of Health, Labour and Welfare has recommended allowing imports of cannabis for medical use.
  • The joint venture of Wellnex Life and OneLife Botanicals has completed the acquisition of MediPharm Labs Australia.
  • Cronos has secured two licences from the Victorian government to enable the operation of the MDC.
  • A medical cannabis study into easing the symptoms of children in palliative care is set to take place in Australia.

Highlights

Share this story
Africa & The Middle East
  • Intercure is in negotiations for the purchase of Cannassure, but no binding agreement has been signed.
  • A study in Israel discovers that CBD is highly effective in adults with refractory epilepsy.
  • BetterSeeds announces that the first-ever shipment of medical cannabis seeds from Israel has arrived in Canada.
  • Panaxia and Neuraxpharm are set to enter new medical cannabis markets in the Czech Republic and Switzerland.
  • The African Hemp and Cannabis Report suggests corporate firms should be taxed to fund mental health programmes.
  • Avant Brands and IM Cannabis jointly announced the launch of BLKMKT in Israel.
Latest Issues

275

274

273

272

271

270

Insights

on the global cannabis industry

International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.